PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
IBB vs. XBIT
Performance
Return for Risk
Drawdowns
Volatility
Dividends

IBB vs. XBIT

Last updated Jun 24, 2026

IBB (iShares Nasdaq Biotechnology ETF) is Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index, while XBIT (XBiotech Inc.) is a stock. Over the past 10 years, IBB returned 8.21%/yr vs -17.34%/yr for XBIT. At a 0.30 correlation, their price movements are largely independent.

Performance

IBB vs. XBIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Nasdaq Biotechnology ETF (IBB) and XBiotech Inc. (XBIT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBB achieves a 5.61% return, which is significantly higher than XBIT's -2.51% return. Over the past 10 years, IBB has outperformed XBIT with an annualized return of 8.21%, while XBIT has yielded a comparatively lower -17.34% annualized return.

IBB

1D
0.62%
1M
5.52%
YTD
5.61%
6M
3.57%
1Y
42.90%
3Y*
11.80%
5Y*
2.21%
10Y*
8.21%

XBIT

1D
0.87%
1M
-4.12%
YTD
-2.51%
6M
-5.28%
1Y
-10.04%
3Y*
-27.20%
5Y*
-30.61%
10Y*
-17.34%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBB vs. XBIT - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
IBB
iShares Nasdaq Biotechnology ETF		5.61%27.98%-2.41%3.76%-13.69%0.95%26.01%25.42%-9.53%21.08%
XBIT
XBiotech Inc.		-2.51%-39.49%-1.25%13.96%-68.46%-17.46%-16.15%267.42%28.93%-61.07%

Correlation

The correlation between IBB and XBIT is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (5Y)
Calculated over the trailing 5-year period

0.32

Correlation (10Y)
Calculated over the trailing 10-year period

0.31

Correlation (All Time)
Calculated using the full available price history since Apr 15, 2015

0.30

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

iShares Nasdaq Biotechnology ETF

XBiotech Inc.

Often compared with IBB:
IBB vs. XBIIBB vs. ARKGIBB vs. XLVIBB vs. IBBQIBB vs. BBHIBB vs. SPYIBB vs. FBIOX
Often compared with XBIT:
XBIT vs. XBIXBIT vs. XBIOXBIT vs. AHCOXBIT vs. IBIOXBIT vs. IHIXBIT vs. SPYL.DEXBIT vs. VHT

Return for Risk

IBB vs. XBIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
IBB
IBB Risk / Return Rank: 7171
Overall Rank
IBB Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
IBB Sortino Ratio Rank: 6868
Sortino Ratio Rank
IBB Omega Ratio Rank: 6060
Omega Ratio Rank
IBB Calmar Ratio Rank: 8585
Calmar Ratio Rank
IBB Martin Ratio Rank: 7575
Martin Ratio Rank
XBIT
XBIT Risk / Return Rank: 3434
Overall Rank
XBIT Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
XBIT Sortino Ratio Rank: 3333
Sortino Ratio Rank
XBIT Omega Ratio Rank: 3333
Omega Ratio Rank
XBIT Calmar Ratio Rank: 3434
Calmar Ratio Rank
XBIT Martin Ratio Rank: 3636
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBB vs. XBIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and XBiotech Inc. (XBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

IBBXBITDifference
Sharpe ratioReturn per unit of total volatility
2.12
-0.20

+2.32

Sortino ratioReturn per unit of downside risk
2.96
0.06

+2.90

Omega ratioGain probability vs. loss probability

1.35

1.01

+0.34

Calmar ratioReturn relative to maximum drawdown

4.47

-0.26

+4.73

Martin ratioReturn relative to average drawdown

13.77

-0.37

+14.14

IBB vs. XBIT - Sharpe Ratio Comparison

The current IBB Sharpe Ratio is 2.12, which is higher than the XBIT Sharpe Ratio of -0.20. The chart below compares the historical Sharpe Ratios of IBB and XBIT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

IBB vs. XBIT - Drawdown Comparison

The maximum IBB drawdown since its inception was -62.85%, smaller than the maximum XBIT drawdown of -92.67%. Use the drawdown chart below to compare losses from any high point for IBB and XBIT.

Loading charts...

Drawdown Indicators

IBBXBITDifference

Max Drawdown

Largest peak-to-trough decline

-62.85%

-92.67%

+29.82%

Max Drawdown (1Y)

Largest decline over 1 year

-9.63%

-39.43%

+29.80%

Max Drawdown (3Y)

Largest decline over 3 years

-24.85%

-78.56%

+53.71%

Max Drawdown (5Y)

Largest decline over 5 years

-39.82%

-87.21%

+47.39%

Max Drawdown (10Y)

Largest decline over 10 years

-39.82%

-90.72%

+50.90%

Current Drawdown

Current decline from peak

0.00%

-91.42%

+91.42%

Average Drawdown

Average peak-to-trough decline

-21.14%

-70.17%

+49.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.12%

26.82%

-23.70%

Volatility

IBB vs. XBIT - Volatility Comparison

iShares Nasdaq Biotechnology ETF (IBB) has a higher volatility of 6.95% compared to XBiotech Inc. (XBIT) at 4.90%. This indicates that IBB's price experiences larger fluctuations and is considered to be riskier than XBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

IBBXBITDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.95%

4.90%

+2.05%

Volatility (6M)

Calculated over the trailing 6-month period

15.98%

21.88%

-5.90%

Volatility (1Y)

Calculated over the trailing 1-year period

20.34%

51.00%

-30.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.03%

64.05%

-42.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.17%

75.11%

-51.94%

Dividends

IBB vs. XBIT - Dividend Comparison

IBB's dividend yield for the trailing twelve months is around 0.23%, while XBIT has not paid dividends to shareholders.

PositionTTM20252024202320222021202020192018201720162015
IBB
iShares Nasdaq Biotechnology ETF		0.23%0.23%0.29%0.26%0.31%0.21%0.21%0.33%0.20%0.30%0.19%0.03%
XBIT
XBiotech Inc.		0.00%0.00%0.00%0.00%0.00%22.46%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

IBB and XBIT have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBB has higher volatility (6.95%) compared to XBIT (4.90%). In terms of maximum drawdown, IBB dropped -62.85% vs XBIT's -92.67%.

IBB currently has the higher Sharpe Ratio (2.12 vs -0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBB and XBIT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer